Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

TURAN, Nedim; Benekli, Mustafa; DANE, FAYSAL; Unal, Olcun; Kara, Hasan; KOCA, Dogan; BALVAN, Ozlem; EREN, Tulay; Tastekin, DİDEM; HELVACI, Kaan; Berk, Veli; DEMIRCI, Umut; Ozturk, Selcuk; DOGAN, Erkan; CETIN, Bulent; Kucukoner, Mehmet; TONYALI, Önder; TUFAN, Gulnihal; Oztop, Ilhan; GUMUS, Mahmut; Coskun, Ugur; Uner, Aytug; Ozet, Ahmet; Buyukberber, Suleyman

doi:10.1111/1759-7714.12107

Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

TURAN N., Benekli M., DANE F., Unal O. U., Kara H. V., KOCA D., ...More

Thoracic cancer, vol.5, no.5, pp.398-404, 2014 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 5 Issue: 5
Publication Date: 2014
Doi Number: 10.1111/1759-7714.12107
Journal Name: Thoracic cancer
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.398-404
Istanbul University Affiliated: Yes

Abstract

Introduction: We investigated the impact of modern chemotherapy regimens and bevacizumab following pulmonary metastasectomy (PM) from metastatic colorectal cancer (CRC).